DOJ Targets Hospital Contracting Practices in Landmark Case Against NewYork-Presbyterian

Federal antitrust action signals escalating scrutiny of payer-provider negotiations and pricing power among dominant health systems.

The Department of Justice’s latest antitrust lawsuit against NewYork-Presbyterian highlights a pivotal escalation in federal efforts to reshape the economics of hospital contracting, and CFOs should take note.

The complaint accuses the health system of leveraging its market dominance to impose contract provisions that suppress price competition. Specifically, regulators allege that NewYork-Presbyterian required insurers to include all of its facilities in-network and positioned them in the most favorable benefit tiers, while prohibiting incentives that would steer patients to lower-cost providers.

These provisions, the DOJ argues, effectively insulated the system from competitive pricing pressure and blocked the development of lower-cost insurance products. 

Strategy for CFOs

For CFOs, the DOJ’s action introduces a new layer of regulatory risk into payer contracting strategy. Longstanding provisions, such as anti-steering clauses, most-favored-nation terms, and systemwide inclusion requirements, may face heightened scrutiny or outright prohibition.

CFOs should begin stress-testing contract portfolios against potential enforcement scenarios. That includes modeling revenue exposure if payers gain greater flexibility to tier networks or steer volume toward lower-cost competitors.

Additionally, the case may accelerate a shift toward value-based arrangements and price transparency as differentiators. If courts limit the use of restrictive contracts, systems will need to compete more directly on cost and outcomes—areas that require tighter financial discipline and operational efficiency.

CFOs should also anticipate ripple effects in negotiations with both payers and employers. As regulatory pressure increases, payers may become more aggressive in demanding contract concessions, particularly around network design and pricing flexibility.

The Bigger Picture

The lawsuit zeroes in on a core dynamic shaping healthcare finance: the growing leverage of large, consolidated health systems in payer negotiations. NewYork-Presbyterian, one of the largest providers in New York City, is accused of using “all-or-nothing” contracting strategies that force payers to accept system-wide inclusion or risk excluding a must-have provider from their networks.

For insurers, such arrangements undermine the ability to design tiered or narrow networks, tools that have historically been used to manage cost trends. For employers and consumers, the downstream effect is fewer “budget-conscious” plan options and higher premiums.

The case is not occurring in isolation. It follows a similar DOJ lawsuit against OhioHealth earlier this year and signals a broader regulatory campaign targeting hospital pricing power and contracting practices. Policymakers are increasingly focused on hospital-driven cost growth, with enforcement actions aimed at restoring competitive dynamics in local markets.

NewYork-Presbyterian has pushed back, calling the lawsuit “without merit” and asserting that its contracts are lawful and pro-competitive. The outcome will likely hinge on how courts interpret the balance between scale-driven efficiencies and anticompetitive conduct in provider networks.

In short, the DOJ’s lawsuit is not just a legal challenge—it’s a signal that the rules of engagement in healthcare finance may be changing.